335 related articles for article (PubMed ID: 16670481)
21. The effects of preservatives on the ciliary beat frequency of chicken embryo tracheas.
van de Donk HJ; Muller-Plantema IP; Zuidema J; Merkus FW
Rhinology; 1980 Sep; 18(3):119-33. PubMed ID: 6158083
[TBL] [Abstract][Full Text] [Related]
22. Optimising concentrations of antimicrobial agents in pharmaceutical preparations: Case of an oral solution of glycerol and an ophthalmic solution containing cysteamine.
Chan Hew Wai A; Becasse P; Tworski S; Pradeau D; Planas V
Ann Pharm Fr; 2014 Nov; 72(6):415-21. PubMed ID: 25438652
[TBL] [Abstract][Full Text] [Related]
23. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers.
Kim MS; Choi CY; Kim JM; Chang HR; Woo HY
Br J Ophthalmol; 2008 Nov; 92(11):1518-21. PubMed ID: 18782802
[TBL] [Abstract][Full Text] [Related]
24. Sodium acetate as a preservative in protein hydrolysate solutions.
Frech G; Allen LV; Stiles ML; Levinson RS
Am J Hosp Pharm; 1979 Dec; 36(12):1672-5. PubMed ID: 118672
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of preservative systems in opthalmic suspension of polymyxin B and dexamethasone by linear regression.
Bou-Chacra NA; Pinto TJ; Kaneko TM
Pharmazie; 2007 Mar; 62(3):199-204. PubMed ID: 17416196
[TBL] [Abstract][Full Text] [Related]
26. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops.
Kahook MY; Noecker R
Adv Ther; 2008 Aug; 25(8):743-51. PubMed ID: 18670744
[TBL] [Abstract][Full Text] [Related]
27. Zinc oxide as a new antimicrobial preservative of topical products: interactions with common formulation ingredients.
Pasquet J; Chevalier Y; Couval E; Bouvier D; Bolzinger MA
Int J Pharm; 2015 Feb; 479(1):88-95. PubMed ID: 25527211
[TBL] [Abstract][Full Text] [Related]
28. Control of microbial contamination in unpreserved eyedrops.
Oldham GB; Andrews V
Br J Ophthalmol; 1996 Jul; 80(7):588-91. PubMed ID: 8795368
[TBL] [Abstract][Full Text] [Related]
29. Preservative properties of Calamintha officinalis essential oil with and without EDTA.
Nostro A; Cannatelli MA; Morelli I; Cioni PL; Bader A; Marino A; Alonzo V
Lett Appl Microbiol; 2002; 35(5):385-9. PubMed ID: 12390486
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial activity of endodontic sealers based on calcium hydroxide and MTA.
Tanomaru JM; Tanomaru-Filho M; Hotta J; Watanabe E; Ito IY
Acta Odontol Latinoam; 2008; 21(2):147-51. PubMed ID: 19177851
[TBL] [Abstract][Full Text] [Related]
31. Preservative efficacy in cefuroxime and ceftazidime eye drop formulations.
Barnes AR; Nash S
J Clin Pharm Ther; 1994 Oct; 19(5):327-32. PubMed ID: 7806604
[TBL] [Abstract][Full Text] [Related]
32. Bandage lenses and the use of topical solutions containing preservatives.
Lemp MA
Ann Ophthalmol; 1978 Oct; 10(10):1319-21. PubMed ID: 718037
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system.
Rosenthal RA; Buck SL; Henry CL; Schlech BA
J Ocul Pharmacol Ther; 2006 Dec; 22(6):440-8. PubMed ID: 17238811
[TBL] [Abstract][Full Text] [Related]
34. Degradation of parabens by Pseudomonas beteli and Burkholderia latens.
Amin A; Chauhan S; Dare M; Bansal AK
Eur J Pharm Biopharm; 2010 Jun; 75(2):206-12. PubMed ID: 20206257
[TBL] [Abstract][Full Text] [Related]
35. Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques.
Gupta S; Kaisheva E
AAPS PharmSci; 2003; 5(2):E8. PubMed ID: 12866935
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial and antifungal properties of human cerumen.
Lum CL; Jeyanthi S; Prepageran N; Vadivelu J; Raman R
J Laryngol Otol; 2009 Apr; 123(4):375-8. PubMed ID: 18694532
[TBL] [Abstract][Full Text] [Related]
37. Seven-day viable analysis of some ophthalmic preparations with different concentrations of benzalkonium chloride.
Adil H; Sheikh D; Ahmed I; Sheikh MR; Ali G
Pak J Pharm Sci; 1995 Jul; 8(2):1-10. PubMed ID: 16420997
[TBL] [Abstract][Full Text] [Related]
38. Composition of artificial tear solution affects in vitro Pseudomonas aeruginosa biofilm formation on silicone hydrogel lens.
Yadav MK; Chuck RS; Park CY
J Ocul Pharmacol Ther; 2013; 29(6):591-4. PubMed ID: 23442006
[TBL] [Abstract][Full Text] [Related]
39. Pseudomonas aeruginosa growth in nonsteroidal antiinflammatory solution.
Pinna A
J Cataract Refract Surg; 2010 Oct; 36(10):1793-4. PubMed ID: 20870130
[No Abstract] [Full Text] [Related]
40. Preservatives in nebulizer solutions: risks without benefit.
Beasley R; Fishwick D; Miles JF; Hendeles L
Pharmacotherapy; 1998; 18(1):130-9. PubMed ID: 9469687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
